The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: A pilot trial from the GETH and GELLC (CLL4 trial)
- Montesinos, P.
- Cabrero, M.
- Valcárcel, D.
- Rovira, M.
- García-Marco, J.A.
- Loscertales, J.
- Moreno, C.
- Duarte, R.
- Terol, M.J.
- Villamor, N.
- Abrisqueta, P.
- Caballero, D.
- Sanz, J.
- Delgado, J.
ISSN: 1476-5365, 0268-3369
Año de publicación: 2016
Volumen: 51
Número: 10
Páginas: 1404-1407
Tipo: Carta